Log In
BCIQ
Print this Print this
 

SM04690

  Manage Alerts
Collapse Summary General Information
Company Samumed LLC
DescriptionSmall molecule inhibitor of the Wnt pathway
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationOsteoarthritis
Indication DetailsTreat moderate to severe osteoarthritis (OA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today